DK164259C - Farmaceutisk formulering til langsom frigivelse af den aktive bestanddel og fremgangsmaade til fremstilling af en saadan formulering - Google Patents

Farmaceutisk formulering til langsom frigivelse af den aktive bestanddel og fremgangsmaade til fremstilling af en saadan formulering

Info

Publication number
DK164259C
DK164259C DK247285A DK247285A DK164259C DK 164259 C DK164259 C DK 164259C DK 247285 A DK247285 A DK 247285A DK 247285 A DK247285 A DK 247285A DK 164259 C DK164259 C DK 164259C
Authority
DK
Denmark
Prior art keywords
medicament
preparing
procedure
formula
active ingredient
Prior art date
Application number
DK247285A
Other languages
English (en)
Other versions
DK247285D0 (da
DK164259B (da
DK247285A (da
Inventor
Paul Jonathan Harrison
John Richard Langridge
Christopher John Potter
Original Assignee
Sterwin Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterwin Ag filed Critical Sterwin Ag
Publication of DK247285D0 publication Critical patent/DK247285D0/da
Publication of DK247285A publication Critical patent/DK247285A/da
Publication of DK164259B publication Critical patent/DK164259B/da
Application granted granted Critical
Publication of DK164259C publication Critical patent/DK164259C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • General Preparation And Processing Of Foods (AREA)
DK247285A 1984-06-04 1985-06-03 Farmaceutisk formulering til langsom frigivelse af den aktive bestanddel og fremgangsmaade til fremstilling af en saadan formulering DK164259C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848414220A GB8414220D0 (en) 1984-06-04 1984-06-04 Medicaments in unit dose form
GB8414220 1984-06-04

Publications (4)

Publication Number Publication Date
DK247285D0 DK247285D0 (da) 1985-06-03
DK247285A DK247285A (da) 1985-12-05
DK164259B DK164259B (da) 1992-06-01
DK164259C true DK164259C (da) 1992-10-19

Family

ID=10561912

Family Applications (1)

Application Number Title Priority Date Filing Date
DK247285A DK164259C (da) 1984-06-04 1985-06-03 Farmaceutisk formulering til langsom frigivelse af den aktive bestanddel og fremgangsmaade til fremstilling af en saadan formulering

Country Status (20)

Country Link
US (1) US4806361A (da)
EP (1) EP0164959B1 (da)
JP (1) JPS611614A (da)
KR (1) KR920004094B1 (da)
AT (1) ATE73323T1 (da)
AU (1) AU573006B2 (da)
CA (1) CA1258232A (da)
DE (1) DE3585560D1 (da)
DK (1) DK164259C (da)
ES (1) ES8608863A1 (da)
FI (1) FI87990C (da)
GB (1) GB8414220D0 (da)
GR (1) GR851356B (da)
IL (1) IL75403A (da)
MX (1) MX159928A (da)
NO (1) NO166063C (da)
NZ (1) NZ212268A (da)
PH (1) PH24225A (da)
PT (1) PT80583B (da)
ZA (1) ZA854116B (da)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5862314A (ja) * 1981-10-07 1983-04-13 Mazda Motor Corp 過給機付エンジンの吸気装置
JPS5993939A (ja) * 1982-11-19 1984-05-30 Toyota Motor Corp 内燃機関のノツキング制御装置
JPS6327424A (ja) * 1986-07-17 1988-02-05 Shionogi & Co Ltd 徐放性製剤およびその製造法
JPH01165520A (ja) * 1987-12-23 1989-06-29 Shin Etsu Chem Co Ltd 持続性製剤およびその製造方法
JPH07100665B2 (ja) * 1987-12-23 1995-11-01 信越化学工業株式会社 被覆薬剤の製造方法
US4880636A (en) * 1988-05-13 1989-11-14 Franz Robert M Film coated tablet of ranitidine HCl
US4938968A (en) * 1988-07-26 1990-07-03 Norjec Development Associates, Inc. Controlled release indomethacin
CA2007055A1 (en) * 1989-01-06 1990-07-06 Garth Boehm Theophylline dosage form
US5196203A (en) * 1989-01-06 1993-03-23 F. H. Faulding & Co. Limited Theophylline dosage form
US5330766A (en) * 1989-01-06 1994-07-19 F. H. Faulding & Co. Limited Sustained release pharmaceutical composition
US5202128A (en) * 1989-01-06 1993-04-13 F. H. Faulding & Co. Limited Sustained release pharmaceutical composition
CA2007181C (en) * 1989-01-06 1998-11-24 Angelo Mario Morella Sustained release pharmaceutical composition
US5213811A (en) * 1991-09-13 1993-05-25 Sterling Drug Inc. Oral sustained-release drug compositions
JPH05149118A (ja) * 1991-11-29 1993-06-15 Mitsubishi Motors Corp エンジンの圧縮比を変化させる方法
US5328697A (en) * 1992-02-10 1994-07-12 Mallinckrodt Veterinary, Inc. Compositions and processes for the sustained release of drugs
US7008668B2 (en) 1995-05-09 2006-03-07 Phoqus Pharmaceuticals Limited Powder coating composition for electrostatic coating of pharmaceutical substrates
CZ352197A3 (cs) 1995-05-09 1998-04-15 Colorcon Limited Způsob elektrostatického potahování a zařízení k jeho provádění
GB9623634D0 (en) 1996-11-13 1997-01-08 Bpsi Holdings Inc Method and apparatus for the coating of substrates for pharmaceutical use
FR2758461A1 (fr) * 1997-01-17 1998-07-24 Pharma Pass Composition pharmaceutique presentant une biodisponibilite elevee et son procede de preparation
FR2758459B1 (fr) * 1997-01-17 1999-05-07 Pharma Pass Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
UA65607C2 (uk) * 1998-03-04 2004-04-15 Орто-Макнейл Фармацевтикал, Інк. Фармацевтична композиція (варіанти) та спосіб її приготування
FR2795961B1 (fr) 1999-07-09 2004-05-28 Ethypharm Lab Prod Ethiques Composition pharmaceutique contenant du fenofibrate micronise, un tensioactif et un derive cellulosique liant et procede de preparation
US7863331B2 (en) 1999-07-09 2011-01-04 Ethypharm Pharmaceutical composition containing fenofibrate and method for the preparation thereof
FR2796840B1 (fr) * 1999-07-26 2003-06-20 Ethypharm Lab Prod Ethiques Comprimes faiblement doses et procede de preparation
ES2295062T3 (es) 1999-09-02 2008-04-16 Nostrum Pharmaceuticals, Inc. Formulacion granulada de liberacion sostenida.
GB0002305D0 (en) 2000-02-01 2000-03-22 Phoqus Limited Power material for electrostatic application
JP2002003366A (ja) * 2000-06-23 2002-01-09 Freunt Ind Co Ltd 固形薬剤用水系コーティング剤組成物
GB0407312D0 (en) 2004-03-31 2004-05-05 Phoqus Pharmaceuticals Ltd Method and apparatus for the application of powder material to substrates
JP5461179B2 (ja) * 2007-06-06 2014-04-02 旭化成ケミカルズ株式会社 セルロース系微小核粒子及びその製造方法
CN104023725B (zh) 2011-08-16 2019-04-26 卡迪欧拉有限公司 控释制剂
CA2971071A1 (en) 2014-12-22 2016-06-30 Cardiora Pty Ltd Use of milrinone and derivatives thereof in the treatment of heart failure with preserved ejection fraction (hfpef)

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2921883A (en) * 1957-05-03 1960-01-19 Smith Kline French Lab Novel coating material for medicaments
US2887440A (en) * 1957-08-12 1959-05-19 Dow Chemical Co Enteric coating
US3328256A (en) * 1963-05-27 1967-06-27 William E Gaunt Spherical beads and their production
US3492397A (en) * 1967-04-07 1970-01-27 Warner Lambert Pharmaceutical Sustained release dosage in the pellet form and process thereof
JPS50129727A (da) * 1974-04-04 1975-10-14
FR2313915A1 (fr) * 1976-01-26 1977-01-07 Corneille Gilbert Nouvelle forme galenique d'administration de la vincamine et de ses derives, son procede de preparation et medicaments comprenant cette nouvelle forme
GB1561204A (en) * 1977-06-01 1980-02-13 Ici Ltd Sustained release pharmaceutical composition
US4180559A (en) * 1978-01-05 1979-12-25 Richardson-Merrell Inc. Coated 1-(2-chlorodibenzo[b,f]oxepin-10-yl)-4-methylpiperazine compositions
DD146547A5 (de) * 1978-07-15 1981-02-18 Boehringer Sohn Ingelheim Arzneimittel-retardform mit unloeslichen poroesen diffusionshuellen
JPS5535031A (en) * 1978-09-04 1980-03-11 Shin Etsu Chem Co Ltd Enteric coating composition
SE7813246L (sv) * 1978-12-22 1980-06-23 Haessle Ab Fast farmaceutisk beredning innehallande kroppar med flera ytskikt
US4248858A (en) * 1979-08-09 1981-02-03 American Home Products Corporation Sustained release pharmaceutical compositions
US4313951A (en) * 1979-11-26 1982-02-02 Sterling Drug Inc. 3-Substituted-6-(lower-alkyl)-5-(pyridinyl)-2(1H)-pyridinones, their cardiotonic use and intermediates therefor
IL61501A (en) * 1979-11-26 1984-06-29 Sterling Drug Inc 5-(pyridinyl)-2(1h)-pyridinones,their preparation and pharmaceutical compositions containing them
DE3000979A1 (de) * 1980-01-12 1981-07-23 Dr. Karl Thomae Gmbh, 7950 Biberach Neue dipyridamol-retardformen und verfahren zu ihrer herstellung
DE3126703A1 (de) * 1981-07-07 1983-01-27 Dr. Karl Thomae Gmbh, 7950 Biberach Bromhexin-retardform und verfahren zu ihrer herstellung
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
MX7567E (es) * 1981-12-23 1989-10-27 Yamanouchi Pharma Co Ltd Procedimiento para recubrir nicardipina de accion prolongada
JPS58116414A (ja) * 1981-12-23 1983-07-11 Yamanouchi Pharmaceut Co Ltd ニカルジピン持続性製剤用球形顆粒およびその製造法
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US4415547A (en) * 1982-06-14 1983-11-15 Sterling Drug Inc. Sustained-release pharmaceutical tablet and process for preparation thereof
DE3237575A1 (de) * 1982-10-09 1984-04-12 Dr. Karl Thomae Gmbh, 7950 Biberach Neue orale mopidamolformen
FR2556964A1 (fr) * 1983-12-23 1985-06-28 Ile De France Nouvelles formes galeniques du sulpiride utilisables par voie orale

Also Published As

Publication number Publication date
ES543826A0 (es) 1986-07-16
NZ212268A (en) 1988-10-28
PH24225A (en) 1990-04-10
GR851356B (da) 1985-11-25
US4806361A (en) 1989-02-21
ES8608863A1 (es) 1986-07-16
IL75403A (en) 1988-08-31
KR860000068A (ko) 1986-01-25
NO166063C (no) 1991-05-29
PT80583A (en) 1985-07-01
EP0164959A2 (en) 1985-12-18
DK247285D0 (da) 1985-06-03
AU4323685A (en) 1985-12-12
PT80583B (pt) 1987-09-18
DE3585560D1 (de) 1992-04-16
FI852235L (fi) 1985-12-05
AU573006B2 (en) 1988-05-26
EP0164959A3 (en) 1986-12-17
DK164259B (da) 1992-06-01
ATE73323T1 (de) 1992-03-15
EP0164959B1 (en) 1992-03-11
ZA854116B (en) 1986-01-29
MX159928A (es) 1989-10-06
CA1258232A (en) 1989-08-08
FI87990B (fi) 1992-12-15
JPS611614A (ja) 1986-01-07
DK247285A (da) 1985-12-05
NO852225L (no) 1985-12-05
FI87990C (fi) 1993-03-25
FI852235A0 (fi) 1985-06-04
NO166063B (no) 1991-02-18
GB8414220D0 (en) 1984-07-11
KR920004094B1 (ko) 1992-05-25

Similar Documents

Publication Publication Date Title
DK164259C (da) Farmaceutisk formulering til langsom frigivelse af den aktive bestanddel og fremgangsmaade til fremstilling af en saadan formulering
IL68494A (en) Dihydropyridine derivatives,their production and pharmaceutical compositions comprising them
ATE122668T1 (de) Diarylsubstituierte heterocyclische verbindung, ihre herstellung und arzneimittel und kosmetika daraus.
CA2282082A1 (fr) Microgranules contenant du cisplatine
ATE359777T1 (de) Fenofibratsäure enthaltende pharmazeutische zusammensetzung und deren physiologisch verträgliche salze und derivate
DE69125715D1 (de) Heterozyklische verbindungen
JPS58134033A (ja) 医薬組成物
ES2024993A6 (es) Procedimiento de obtencion de un preparado farmaceutico oral conteniendo omeprazol.
ATE104146T1 (de) Zubereitung mit verzoegerter freigabe eines hydrochlorids eines basischen arzneistoffs.
EP0271151A3 (en) Azumolene dosage form
DK0466586T3 (da) Disubstituerede polymethyleniminer, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
ATE45090T1 (de) Pharmazeutische zusammensetzung in oralen darreichungsformen.
IE37288B1 (en) Pharmaceutical compositions for use in the treatment of certain respiratory diseases or conditions in prematurely born children
NO823682L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyridazinonimin-derivater.
BE880648A (fr) Nouvelles formes galeniques d'administration de medicaments par voie orale, aliberation programmee et leurs procedes de preparation
KR940001887A (ko) 신규 경구제형
IE43848L (en) Pharmaceutical compositions
IT1251496B (it) Derivati imidazotiadiazolici ad attivita' diuretica, procedimenti per la loro preparazione e composizioni che li contengono
JPS57112329A (en) Drug against arterioschlerosis comprising 2,3- dihydroxypropyl ester of n-(7-chloro-4-quinolyl) anthranillic acid

Legal Events

Date Code Title Description
PBP Patent lapsed